| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $5,628,547 ) |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 001 | 2 | NIH | 2/27/2023 | $54,956 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 000 | 2 | NIH | 1/31/2023 | $151,756 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21AI168799 | Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy | 000 | 2 | NIH | 1/17/2023 | $233,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 001 | 2 | NIH | 2/16/2023 | $421,449 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00ES031148 | Repair of Oxidative Damage in G-Quadruplex Promoter DNA | 000 | 4 | NIH | 2/24/2023 | $249,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 9 | NIH | 1/26/2023 | $561,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01HL150190 | The role of microhomology-mediated end joining in Fanconi anemia pathogenesis | 000 | 4 | NIH | 1/26/2023 | $467,500 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA248655 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | 001 | 4 | NIH | 2/28/2023 | $602,047 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 000 | 1 | NIH | 2/10/2023 | $430,050 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA238061 | Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities | 000 | 5 | NIH | 3/8/2023 | $578,893 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA280446 | Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways | 000 | 1 | NIH | 3/22/2023 | $255,105 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 7 | NIH | 1/4/2023 | $433,373 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 1 | NIH | 12/16/2022 | $758,985 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K99GM148819 | Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation | 000 | 1 | NIH | 1/17/2023 | $125,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 2 | NIH | 11/21/2022 | $494,601 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 000 | 2 | NIH | 11/8/2022 | $420,750 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 001 | 2 | NIH | 3/23/2023 | $46,750 |
| | 2023 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U54CA272686 | Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center | 000 | 1 | NIH | 1/9/2023 | $0 |
| | 2023 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA248655 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | 000 | 3 | NIH | 11/4/2022 | $0 |
| | 2023 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM102503 | The Role of Histone Chaperones in Histone Acetylation and Nucleosome Dynamics | 000 | 8 | NIH | 1/9/2023 | -$486,200 |
| | 2023 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K08CA267313 | Addressing Colorectal Cancer-Related Distress: Developing and Evaluating a Couple-Based Mindfulness Intervention | 000 | 1 | NIH | 1/5/2023 | -$169,468 |
| | 2023 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 000 | 1 | NIH | 11/9/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $19,574,030 ) (Continued on the next page) |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM102503 | The Role of Histone Chaperones in Histone Acetylation and Nucleosome Dynamics | 000 | 8 | NIH | 6/9/2022 | $498,606 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 017 | 55 | NIH | 8/3/2022 | $0 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 011 | 55 | NIH | 5/13/2022 | $400,000 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 010 | 55 | NIH | 5/12/2022 | $250,000 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03HS029223 | Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Using Real-World Data | 000 | 1 | AHRQ | 8/30/2022 | $50,000 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K08CA267313 | Addressing Colorectal Cancer-Related Distress: Developing and Evaluating a Couple-Based Mindfulness Intervention | 000 | 1 | NIH | 8/12/2022 | $174,306 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01HL150190 | The role of microhomology-mediated end joining in Fanconi anemia pathogenesis | 001 | 3 | NIH | 6/15/2022 | $45,409 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 016 | 55 | NIH | 8/2/2022 | $0 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA222124 | Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention | 000 | 5 | NIH | 8/17/2022 | $600,882 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA256234 | Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer | 000 | 2 | NIH | 11/16/2021 | $93,500 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD012621 | Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants? | 001 | 5 | NIH | 4/17/2022 | $85,441 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD012621 | Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants? | 000 | 5 | NIH | 12/16/2021 | $768,973 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 8 | NIH | 1/10/2022 | $561,000 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U01CA260369 | Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients | 000 | 2 | NIH | 8/1/2022 | $414,249 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI144400 | Targeting RIPK3 in Flu-Associated Lung Injury | 000 | 4 | NIH | 8/23/2022 | $731,691 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA238061 | Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities | 000 | 4 | NIH | 4/11/2022 | $578,891 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM135293 | Dissecting BRCA1-PALB2 Activity in DNA Repair and Development | 000 | 3 | NIH | 7/13/2022 | $408,313 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA236391 | Novel Role of ThPOK in Mammary Carcinoma | 001 | 4 | NIH | 4/25/2022 | $50,831 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA236391 | Novel Role of ThPOK in Mammary Carcinoma | 000 | 4 | NIH | 3/22/2022 | $571,833 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00ES031148 | Repair of Oxidative Damage in G-Quadruplex Promoter DNA | 001 | 3 | NIH | 4/27/2022 | $0 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00ES031148 | Repair of Oxidative Damage in G-Quadruplex Promoter DNA | 000 | 3 | NIH | 3/3/2022 | $249,000 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 001 | 2 | NIH | 9/1/2022 | $8,313 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 000 | 2 | NIH | 3/30/2022 | $407,062 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 1 | NIH | 1/18/2022 | $549,557 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA251674 | Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma | 000 | 2 | NIH | 5/16/2022 | $427,763 |
| | 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA248655 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | 002 | 3 | NIH | 9/21/2022 | $425,750 |
|
